Detalhe da pesquisa
1.
Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia.
Acta Haematol
; 146(2): 166-171, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273464
2.
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial.
Haematologica
; 107(9): 2108-2120, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35021599
3.
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.
Ann Hematol
; 100(7): 1733-1742, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34018029
4.
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 20(1): 43-56, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522969
5.
Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies.
Am J Hematol
; 93(11): 1402-1410, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30129285
6.
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
N Engl J Med
; 371(3): 213-23, 2014 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24881631
7.
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Haematologica
; 102(2): 356-363, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28143954
8.
A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Haematologica
; 105(4): e164-e168, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31413095
9.
Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.
Nephrol Dial Transplant
; 30(10): 1774-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26188340
10.
CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy.
Am J Hematol
; 88(4): 273-6, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23460351
11.
Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma.
Am J Hematol
; 87(3): 258-65, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22213215
12.
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Lancet Oncol
; 12(11): 1013-22, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21940214
13.
SIRPα Suppresses Response to Therapeutic Antibodies by Nurse Like Cells From Chronic Lymphocytic Leukemia Patients.
Front Immunol
; 11: 610523, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33552071
14.
PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia.
Leukemia
; 34(2): 451-461, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462739
15.
Author Correction: Diagnosis of fusion genes using targeted RNA sequencing.
Nat Commun
; 11(1): 1810, 2020 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32269228
16.
Diagnosis of fusion genes using targeted RNA sequencing.
Nat Commun
; 10(1): 1388, 2019 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30918253
17.
Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis.
Nat Clin Pract Oncol
; 5(4): 234-8, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18285762
18.
Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
Am J Hematol
; 83(4): 330-3, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17876769
19.
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Clin Lymphoma Myeloma Leuk
; 18(12): 803-813.e7, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30249389
20.
Pharmaceutical impurities: regulatory perspective for Abbreviated New Drug Applications.
Adv Drug Deliv Rev
; 59(1): 64-72, 2007 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-17196703